Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)
Phase of Trial: Phase IV
Latest Information Update: 21 Dec 2016
At a glance
- Drugs Vorapaxar (Primary) ; Aspirin
- Indications Thrombosis
- Focus Therapeutic Use
- Acronyms XLPAD-TRACE
- 27 Jul 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Jul 2017.
- 27 Jul 2016 Status changed from not yet recruiting to recruiting.
- 23 Mar 2016 Study design changed from open label to double blind; patients' minimum age changed from 18 years to 40 years, according to ClinicalTrials.gov record.